Goldman Sachs’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding BCAT
PCM
Goldman Sachs's BCAT Position: Q2 2026 in Review
Goldman Sachs sold out of BlackRock Capital Allocation Term Trust (BCAT) in Q2 2026, closing a stake of 12,800 shares — an estimated $181K sold.
Goldman Sachs first reported a position in BCAT in Q3 2023 and held it in 2 quarters. The position peaked at $713K in Q3 2023. 110 funds tracked by Wall St. Rank hold BCAT as of Q2 2026.
- Goldman Sachs reported no remaining BlackRock Capital Allocation Term Trust position as of Q2 2026 after selling out during the quarter.
- Goldman Sachs sold 12,800 BlackRock Capital Allocation Term Trust shares in Q2 2026, an estimated $181K.
- Goldman Sachs first reported a position in BlackRock Capital Allocation Term Trust in Q3 2023 and held it in 2 quarters.
- Goldman Sachs's BlackRock Capital Allocation Term Trust position peaked at $713K in Q3 2023.
- 110 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q2 2026.
Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.